Physician profile
Pramod Menon
NPI 1588620611
$53,613.81
in general payments reported to CMS, 2019-2025
61 companies · $3,297 in 2025
The $3,297 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $11K · 2021: $14K · 2022: $4,918 · 2023: $5,212 · 2024: $3,085 · 2025: $3,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Consulting Fee: $1,250 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,333.35 |
| Consulting Fee | $1,250.00 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18,378.22 | 2019-2023 | Wainua |
| Terumo Medical Corporation | $11,604.11 | 2019-2025 | Navicross, R2p Misago, Glidesheath Slender |
| Edwards Lifesciences Corporation | $3,943.06 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Medtronic, INC. | $3,403.29 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Resolute Onyx |
| Boston Scientific Corporation | $2,421.74 | 2019-2025 | Eluvia, General - Vascular Intervention, Peripheral Rotalink Plus |
| Abiomed | $2,306.74 | 2019-2023 | Impella |
| Cardiovascular Systems INC. | $1,031.48 | 2019-2022 | |
| Pfizer INC. | $850.83 | 2019-2025 | |
| Abbott Laboratories | $827.49 | 2020-2024 | Diamondback Peripheral, Cardiomems, Assurity |
| Merck Sharp & Dohme LLC | $685.24 | 2021-2025 | Verquvo, Belsomra |
| Janssen Pharmaceuticals, INC | $683.86 | 2019-2024 | Xarelto |
| Amgen INC. | $610.88 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $570.53 | 2020-2025 | |
| Novo Nordisk INC | $471.77 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Medtronic Vascular, INC. | $447.21 | 2019-2020 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $354.38 | 2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $332.30 | 2021-2022 | |
| Philips North America LLC | $331.35 | 2019-2024 | (Az7) Lasers |
| Sanofi-Aventis U.S. LLC | $323.58 | 2019-2023 | |
| Amarin Pharma, INC. | $323.04 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $322.26 | 2019-2025 | Camzyos |
| Z-Medica, LLC | $308.12 | 2020 | |
| Shockwave Medical, INC | $258.14 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Esperion Therapeutics, INC. | $241.80 | 2020-2025 | Nexletol |
| Angiodynamics, INC. | $238.97 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $207.87 | 2021-2025 | Lifevest |
| Surmodics, INC. | $189.81 | 2021-2023 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 014, 65cm, Straight, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Kowa Pharmaceuticals America, INC. | $167.52 | 2019-2023 | Livalo |
| Recor Medical INC | $159.88 | 2024 | Paradise Renal Denervation System |
| Inari Medical, INC. | $145.76 | 2022 | |
| Stryker Corporation | $140.64 | 2025 | Flowtriever |
| Inspire Medical Systems, INC. | $137.57 | 2022-2025 | Inspire |
| Tactile Systems Technology INC | $136.19 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.67 | 2019-2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $96.49 | 2019-2025 | Evkeeza |
| Teleflex LLC | $93.39 | 2021-2024 | Guideliner |
| Astellas Pharma US INC | $84.92 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.47 | 2021-2025 | |
| Arbor Pharmaceuticals, INC. | $59.39 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $58.62 | 2021-2023 | Arcalyst |
| Penumbra, INC. | $45.49 | 2023-2024 | Indigo System, Smart Coil |
| Atricure, INC. | $41.59 | 2024 | |
| Biotronik INC. | $39.31 | 2019 | |
| Glaxosmithkline, LLC. | $35.51 | 2021-2022 | |
| Lilly USA, LLC | $33.73 | 2025 | Zepbound, Mounjaro |
| Lundbeck LLC | $32.42 | 2019-2020 | |
| Irhythm Technologies, INC. | $29.39 | 2022 | |
| Acist Medical Systems, INC. | $28.98 | 2020 | |
| Cvrx, INC. | $24.19 | 2024 | Barostim Neo System |
| Itamar Medical INC | $23.84 | 2025 | Watchpatone |
| Kiniksa Pharmaceuticals International, Plc | $23.03 | 2024 | Arcalyst |
| Baxter Healthcare | $21.19 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Scpharmaceuticals INC. | $19.26 | 2025 | |
| Celonova Biosciences, INC. | $18.01 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $16.79 | 2022 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $14.82 | 2019 | |
| Chiesi USA, INC. | $13.57 | 2023 | Kengreal |
| Medicure Pharma INC. | $10.35 | 2019 | |
| Bardy Diagnostics, INC. | $1.76 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pramod Menon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.